Doctors can use the new system to diagnose and treat diseases linked with chromosomal abnormalities. Credit: Victoria_Watercolor via Pixabay.

China-based medical enterprise Diagens Biotechnology has introduced a new chromosomal karyotyping system, MetaSight G200.

Built using high-resolution microscopy technology, the third-generation karyotyping system can precisely identify chromosomal abnormalities in humans.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

It automates and streamlines traditional karyotyping processes, enabling doctors to diagnose and treat diseases linked with chromosomal abnormalities with increased accuracy.

Diagens Biologics founder Dr Ning Song said: “The introduction of the MetaSight G200 system represents another significant breakthrough for us in the field of medical testing.

“This system will undoubtedly foster innovation and development within the industry, providing doctors and patients with more precise and reliable test results, ultimately contributing to the advancement of human health.”

MetaSight G200 system has the potential to intelligently acquire the optimal metaphase image and complete a single slide scan within four minutes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The system offers quality cell images by using state-of-the-art optical imaging technology and image sensors.

It is claimed to be the world’s first model to be installed with a chromosome defect recognition analysis module, which automatically labels chromosomal abnormalities.

The system provides smooth and stable operation thanks to an integrated microstructure design, a zigzag electric scanning platform and a contactless magnetic levitation motor.

Diagens Biotechnology is engaged in the research and development of reproductive prenatal devices and intelligent systems.

The company offers products and services for clinical hospitals, research institutes and the public.